UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression

Scientific reports, 2023-05, Vol.13 (1), p.8779-8779, Article 8779

2023

Volltextzugriff (PDF)

Central nervous system metastasis in gynecologic cancers: Seeking the prognostic factors

Journal of cancer research and therapeutics, 2023-12, Vol.19 (Suppl 2), p.S523-S529

2023

Volltextzugriff (PDF)

Outcomes of the patients with metastatic male breast cancer

Journal of cancer research and therapeutics, 2024-01, Vol.20 (1), p.98-102

2024

Volltextzugriff (PDF)

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors

Journal of cancer research and therapeutics, 2023-10, Vol.19 (7), p.1945-1949

2023

Volltextzugriff (PDF)

Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

Frontiers in oncology, 2023-07, Vol.13, p.1165257-1165257

2023

Volltextzugriff (PDF)

The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial

The American journal of surgery, 2011-07, Vol.202 (1), p.10-15

2011

Volltextzugriff (PDF)

Clinicopathologic characteristics and prognostic factors in patients with male breast cancer: A single tertiary center experience

Journal of cancer research and therapeutics, 2023-10, Vol.19 (7), p.1887-1892

2023

Volltextzugriff (PDF)

Does visceral adiposity have an effect on the survival outcomes of the patients with endometrial cancer?

The journal of obstetrics and gynaecology research, 2021-02, Vol.47 (2), p.560-569

2021

Volltextzugriff (PDF)

Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine

European journal of breast health, 2023-04, Vol.19 (2), p.128-133

2023

Volltextzugriff (PDF)

High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma

Journal of ovarian research, 2021-10, Vol.14 (1), p.131-131, Article 131

2021

Volltextzugriff (PDF)

Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients

European journal of breast health, 2022-10, Vol.18 (4), p.323-328

2022

Volltextzugriff (PDF)

Evaluation of BRCA1/2 gene mutations in patients with high-risk breast and/or ovarian cancer in Turkey

Türk biyokimya dergisi, 2022-10, Vol.47 (5), p.588-594

2022

Volltextzugriff (PDF)

Henna Application in the Prevention of Capecitabine-Induced Hand-Foot Syndrome in Breast and Colorectal Cancer Patients

Florence nightingale journal of nursing, 2020-10, Vol.28 (3), p.299-311

2020

Volltextzugriff (PDF)

Abbreviated and Standard Breast MRI in Neoadjuvant Chemotherapy Response Evaluation: A Comparative Study

Current medical imaging reviews, 2022-01, Vol.18 (10), p.1052-1060

2022

Volltextzugriff (PDF)

Cost effectiveness of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in a Middle-Income Country, Turkey: Results of a Prospective Multicenter Study

European journal of breast health, 2019-07, Vol.15 (3), p.183-190

2019

Volltextzugriff (PDF)

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma

Türk onkoloji dergisi, 2021

ak, naziye

2021

Volltextzugriff (PDF)

In patients with advanced ovarian cancer, primary suboptimal surgery has better survival outcome than interval suboptimal surgery

Journal of the Turkish German Gynecological Association, 2019-03, Vol.20 (1), p.31-36

2019

Volltextzugriff (PDF)

Myelodysplastic Syndrome After Olaparib Treatment in Heavily Pretreated Ovarian Carcinoma

American journal of therapeutics, 2019-09, Vol.26 (5), p.e632-e633

2019

Volltextzugriff (PDF)

Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey

Curēus (Palo Alto, CA), 2016-03

2016

Volltextzugriff (PDF)

Comparison of bevacizumab plus doublet chemotherapy regimens in patients with metastatic or recurrent ovarian cancer

Journal of clinical oncology, 2023-06, Vol.41 (16_suppl), p.e17537-e17537

2023

Volltextzugriff (PDF)

Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer

European journal of breast health, 2018-04, Vol.14 (2), p.93-99

2018

Volltextzugriff (PDF)

Rapid drug desensitization for platinum‐based chemotherapy drugs significantly increases peripheral blood IL‐10 levels

Allergy (Copenhagen), 2020-11, Vol.75 (11), p.2942-2945

2020

Volltextzugriff (PDF)

Myelodysplastic Syndrome After Olaparib Treatment in Heavily Pretreated Ovarian Carcinoma

American journal of therapeutics, 2018-08, p.1

2018

Volltextzugriff (PDF)

Skeletal system as a rare metastatic site in patients with ovarian carcinoma

International journal of gynecological cancer, 2021-08, Vol.31 (8), p.1125-1131

2021

Volltextzugriff (PDF)

Cost-Effectiveness of Breast Cancer Screening in Turkey, a Developing Country: Results from Bahçeşehir Mammography Screening Project

European journal of breast health, 2017-07, Vol.13 (3), p.117-122

2017

Volltextzugriff (PDF)

1 – 25 von 147

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(133)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Englisch
(146)
Türkisch
(3)

Erscheinungsjahr

n.n

Thema

Science & Technology
(104)
Life Sciences & Biomedicine
(103)
Humans
(69)
Oncology
(67)
Female
(61)
Middle Aged
(53)
Adult
(51)
Aged
(40)
Breast Cancer
(39)
Prognosis
(35)
Chemotherapy
(24)
Retrospective Studies
(24)
Biological And Medical Sciences
(22)
Medical Sciences
(22)
Tumors
(22)
Ovarian Cancer
(19)
Male
(17)
Ovarian Neoplasms - Pathology
(16)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(15)
Metastasis
(15)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Termination of trastuzumab in HER2-positive metastatic breast cancer patients who received trastuzumab beyond progression

Central nervous system metastasis in gynecologic cancers: Seeking the prognostic factors

Outcomes of the patients with metastatic male breast cancer

Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors

Diverging prognostic effects of CD155 and CD73 expressions in locally advanced triple-negative breast cancer

The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial

Clinicopathologic characteristics and prognostic factors in patients with male breast cancer: A single tertiary center experience

Does visceral adiposity have an effect on the survival outcomes of the patients with endometrial cancer?

Prognostic Factors Influencing Progression-Free Survival in HER2-Positive Metastatic Breast Cancer Patients Who Were Treated With A Combination of Lapatinib and Capecitabine

High expression level of miR-1260 family in the peripheral blood of patients with ovarian carcinoma

Comparison of Clinical, Pathological, and Prognostic Features in BRCA Mutant and Wild-Type Male Breast Cancer Patients

Evaluation of BRCA1/2 gene mutations in patients with high-risk breast and/or ovarian cancer in Turkey

Henna Application in the Prevention of Capecitabine-Induced Hand-Foot Syndrome in Breast and Colorectal Cancer Patients

Abbreviated and Standard Breast MRI in Neoadjuvant Chemotherapy Response Evaluation: A Comparative Study

Cost effectiveness of Gene Expression Profiling in Patients with Early-Stage Breast Cancer in a Middle-Income Country, Turkey: Results of a Prospective Multicenter Study

Evaluation of Prognostic and Predictive Values of Hemogram Parameters in Patients with Advanced Stage Ovarian Carcinoma

In patients with advanced ovarian cancer, primary suboptimal surgery has better survival outcome than interval suboptimal surgery

Myelodysplastic Syndrome After Olaparib Treatment in Heavily Pretreated Ovarian Carcinoma

Impact of Oncotype DX Recurrence Score on Treatment Decisions: Results of a Prospective Multicenter Study in Turkey

Comparison of bevacizumab plus doublet chemotherapy regimens in patients with metastatic or recurrent ovarian cancer

Frequency of Rearrangements Versus Small Indels Mutations in BRCA1 and BRCA2 Genes in Turkish Patients with High Risk Breast and Ovarian Cancer

Rapid drug desensitization for platinum‐based chemotherapy drugs significantly increases peripheral blood IL‐10 levels

Myelodysplastic Syndrome After Olaparib Treatment in Heavily Pretreated Ovarian Carcinoma

Skeletal system as a rare metastatic site in patients with ovarian carcinoma

Cost-Effectiveness of Breast Cancer Screening in Turkey, a Developing Country: Results from Bahçeşehir Mammography Screening Project

Suchergebnisse filtern